Lower riskDrug recall · FDA · Published February 9, 2024
HydrALAZINE 10mg Tablets Recall: Remote Risk of Temporary Health Effects
Major Pharmaceuticals recalls HydrALAZINE Hydrochloride 10mg tablets (Lot T04680) due to a remote possibility of temporary health effects from impurities. No immediate action needed as the risk is low.
an out of specification result obtained during routine stability testing for Impurities. There is a remote possibility that use of this product could cause a medically reversible or transient adverse health consequences.
Take action
Contact the company
📍Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
“HydrALAZINE 10mg Tablets Recall: Remote Risk of Temporary Health Effects.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32824-hydralazine-10mg-tablets-recall-remote-risk-of-temporary-health-effects. Based on FDA recall #D-0324-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0324-2024%22&limit=1).
The FDA announced on Feb. 9, 2024, that Major Pharmaceuticals is recalling HydrALAZINE Hydrochloride Tablets, USP 10mg due to out-of-specification impurities. The agency classified the recall as Class II.
The recall stems from an out-of-specification result obtained during routine stability testing for impurities. The FDA stated there is a remote possibility that use of this product could cause medically reversible or transient adverse health consequences.
Context
GovInfoNow's records show Major Pharmaceuticals has 14 other recalls on record since May 31, 2023. Recent brand recalls include a Sept. 12, 2025, recall of Major Chlorpromazine 50mg Tablets for N-Nitroso Desmethyl Chlorpromazine risk and a Sept. 2, 2025, recall of Major Pharmaceuticals Sulfamethoxazole-Trimethoprim for foreign microorganism risk. Other recent recalls of similar products include Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026), Ajanta Pharma Fluphenazine Tablets Recall (Aug. 25, 2026), and Hikma Ramipril Capsules 10mg Recall (Aug. 24, 2026).
How to tell if you have this one
Check for HydrALAZINE Hydrochloride 10mg tablets in 100-count blister packs with Lot Number T04680. The product is prescription-only and distributed by Major Pharmaceuticals.
Brand
Major Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number T04680 on the blister pack to confirm if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “The product was distributed nationwide within the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0324-2024 (February 9, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0324-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.